Structural and spatial determinants regulating TC21 activation by RasGRF family nucleotide exchange factors.

Fernando Calvo, Piero Crespo
Author Information
  1. Fernando Calvo: Instituto de Biomedicina y Biotecnología de Cantabria, Consejo Superior de Investigaciones Científicas - IDICAN - Universidad de Cantabria, Departamento de Biología Molecular, Facultad de Medicina, Santander, 39011 Cantabria, Spain.

Abstract

RasGRF family guanine nucleotide exchange factors (GEFs) promote guanosine diphosphate (GDP)/guanosine triphosphate (GTP) exchange on several Ras GTPases, including H-Ras and TC21. Although the mechanisms controlling RasGRF function as an H-Ras exchange factor are relatively well characterized, little is known about how TC21 activation is regulated. Here, we have studied the structural and spatial requirements involved in RasGRF 1/2 exchange activity on TC21. We show that RasGRF GEFs can activate TC21 in all of its sublocalizations except at the Golgi complex. We also demonstrate that TC21 susceptibility to activation by RasGRF GEFs depends on its posttranslational modifications: farnesylated TC21 can be activated by both RasGRF1 and RasGRF2, whereas geranylgeranylated TC21 is unresponsive to RasGRF2. Importantly, we show that RasGRF GEFs ability to catalyze exchange on farnesylated TC21 resides in its pleckstrin homology 1 domain, by a mechanism independent of localization and of its ability to associate to membranes. Finally, our data indicate that Cdc42-GDP can inhibit TC21 activation by RasGRF GEFs, demonstrating that Cdc42 negatively affects the functions of RasGRF GEFs irrespective of the GTPase being targeted.

References

  1. J Biol Chem. 2001 Oct 12;276(41):38029-35 [PMID: 11500499]
  2. Br J Cancer. 1998 Aug;78(3):296-300 [PMID: 9703274]
  3. Mol Cell Biol. 2004 Feb;24(4):1516-30 [PMID: 14749369]
  4. Oncogene. 1995 May 18;10(10):1887-93 [PMID: 7761090]
  5. Cell Signal. 1998 Mar;10(3):167-72 [PMID: 9607139]
  6. J Cell Biol. 1994 Jul;126(1):111-26 [PMID: 7517942]
  7. Neurochem Res. 1995 Apr;20(4):457-60 [PMID: 7651583]
  8. Oncogene. 1995 May 18;10(10):1905-13 [PMID: 7761092]
  9. J Biol Chem. 2000 Jun 30;275(26):20020-6 [PMID: 10777492]
  10. J Cell Physiol. 1993 Jun;155(3):437-44 [PMID: 8388000]
  11. J Biol Chem. 2003 Feb 14;278(7):4572-81 [PMID: 12458225]
  12. FEBS Lett. 1999 Oct 29;460(2):357-62 [PMID: 10544264]
  13. J Biol Chem. 1997 Jul 25;272(30):18602-7 [PMID: 9228027]
  14. Neuron. 2003 Nov 13;40(4):775-84 [PMID: 14622581]
  15. Nature. 1995 Aug 10;376(6540):524-7 [PMID: 7637786]
  16. Oncogene. 1999 Oct 21;18(43):5860-9 [PMID: 10557073]
  17. J Biol Chem. 2001 Jun 15;276(24):21878-84 [PMID: 11285260]
  18. J Biol Chem. 2000 Mar 10;275(10):7189-97 [PMID: 10702288]
  19. J Biol Chem. 1998 Jun 26;273(26):16210-5 [PMID: 9632678]
  20. Brain Res Mol Brain Res. 1997 Aug;48(1):140-4 [PMID: 9379834]
  21. Nature. 1996 Jul 18;382(6588):268-72 [PMID: 8717044]
  22. J Biol Chem. 1992 Oct 5;267(28):20033-8 [PMID: 1400319]
  23. Prog Nucleic Acid Res Mol Biol. 2002;71:391-444 [PMID: 12102558]
  24. Mol Cell Biol. 1990 Apr;10(4):1793-8 [PMID: 2108320]
  25. Biochem Biophys Res Commun. 2003 Nov 28;311(4):829-38 [PMID: 14623256]
  26. Biochem J. 2004 Feb 15;378(Pt 1):129-39 [PMID: 14567755]
  27. Blood. 2002 Sep 1;100(5):1835-44 [PMID: 12176907]
  28. J Biol Chem. 2003 Aug 29;278(35):33465-73 [PMID: 12782630]
  29. Physiol Rev. 2001 Jan;81(1):153-208 [PMID: 11152757]
  30. Oncogene. 2004 Jan 15;23(2):368-78 [PMID: 14724565]
  31. Oncogene. 1996 Jan 4;12(1):169-76 [PMID: 8552388]
  32. J Biol Chem. 2000 Feb 18;275(7):5222-7 [PMID: 10671570]
  33. J Biol Chem. 1997 Feb 14;272(7):4398-403 [PMID: 9020162]
  34. Mol Cell Biol. 2001 Jun;21(11):3750-62 [PMID: 11340168]
  35. Genes Dev. 2002 Jul 1;16(13):1587-609 [PMID: 12101119]
  36. J Biol Chem. 2002 Mar 22;277(12):9966-75 [PMID: 11788587]
  37. EMBO J. 2004 Apr 7;23(7):1567-75 [PMID: 15029245]
  38. Curr Biol. 1998 Jul 30-Aug 13;8(16):935-8 [PMID: 9707409]
  39. Oncogene. 1995 Oct 5;11(7):1255-60 [PMID: 7478545]
  40. Mol Carcinog. 2005 Feb;42(2):97-108 [PMID: 15599930]
  41. Methods Enzymol. 2001;333:333-42 [PMID: 11400349]
  42. J Biol Chem. 1998 Jan 16;273(3):1782-7 [PMID: 9430727]
  43. Curr Opin Cell Biol. 2006 Aug;18(4):351-7 [PMID: 16781855]
  44. Mol Cell Biol. 1997 Mar;17(3):1396-406 [PMID: 9032266]
  45. J Cell Biol. 1999 May 31;145(5):1077-88 [PMID: 10352023]
  46. J Mol Biol. 2004 Oct 15;343(2):417-33 [PMID: 15451670]
  47. Arch Biochem Biophys. 1998 Aug 15;356(2):167-76 [PMID: 9705207]
  48. Mol Cell Biol. 2007 Dec;27(23):8127-42 [PMID: 17923690]
  49. Exp Cell Res. 2000 Aug 1;258(2):403-8 [PMID: 10896791]
  50. FEBS Lett. 1997 Apr 21;407(1):111-5 [PMID: 9141492]
  51. Mol Cell Biol. 2006 Jan;26(1):100-16 [PMID: 16354683]
  52. Cell. 1999 Jul 9;98(1):69-80 [PMID: 10412982]
  53. Oncogene. 1996 Feb 1;12(3):463-70 [PMID: 8637701]
  54. J Biol Chem. 2005 Jan 7;280(1):225-35 [PMID: 15513915]
  55. EMBO J. 1999 Mar 1;18(5):1270-9 [PMID: 10064593]
  56. Mol Cell Biol. 1996 Sep;16(9):4888-96 [PMID: 8756648]
  57. J Biol Chem. 2000 Aug 25;275(34):26441-8 [PMID: 10840034]
  58. Mol Biol Cell. 2005 May;16(5):2458-69 [PMID: 15772154]
  59. Nature. 2003 Aug 7;424(6949):694-8 [PMID: 12845332]
  60. EMBO J. 1998 Aug 17;17(16):4626-38 [PMID: 9707422]
  61. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7558-62 [PMID: 8052619]
  62. Differentiation. 2007 Mar;75(3):193-207 [PMID: 17288543]
  63. Cancer Res. 2005 Jan 15;65(2):507-15 [PMID: 15695393]
  64. Oncogene. 1996 Jun 20;12(12):2697-703 [PMID: 8700529]
  65. Exp Cell Res. 2005 Apr 1;304(2):354-64 [PMID: 15748883]
  66. Mol Biol Cell. 2006 Apr;17(4):2046-56 [PMID: 16467383]
  67. Mol Cell Biol. 2000 Apr;20(8):2727-33 [PMID: 10733575]
  68. J Cell Sci. 2003 Sep 15;116(Pt 18):3729-38 [PMID: 12890755]

MeSH Term

Animals
COS Cells
Chlorocebus aethiops
Enzyme Activation
Guanosine Diphosphate
HeLa Cells
Humans
Ionomycin
Lysophospholipids
Membrane Proteins
Monomeric GTP-Binding Proteins
Organelles
Prenylation
Protein Interaction Mapping
Protein Processing, Post-Translational
Protein Structure, Tertiary
RNA, Small Interfering
Recombinant Fusion Proteins
Structure-Activity Relationship
Subcellular Fractions
Substrate Specificity
cdc42 GTP-Binding Protein
ras Guanine Nucleotide Exchange Factors
ras-GRF1

Chemicals

Lysophospholipids
Membrane Proteins
RASGRF1 protein, human
RASGRF2 protein, human
RNA, Small Interfering
Recombinant Fusion Proteins
ras Guanine Nucleotide Exchange Factors
ras-GRF1
Guanosine Diphosphate
Ionomycin
RRAS2 protein, human
Monomeric GTP-Binding Proteins
cdc42 GTP-Binding Protein
lysophosphatidic acid

Word Cloud

Created with Highcharts 10.0.0TC21RasGRFexchangeGEFsactivationcanfamilynucleotidefactorsH-RasspatialshowfarnesylatedRasGRF2abilityguaninepromoteguanosinediphosphateGDP/guanosinetriphosphateGTPseveralRasGTPasesincludingAlthoughmechanismscontrollingfunctionfactorrelativelywellcharacterizedlittleknownregulatedstudiedstructuralrequirementsinvolved1/2activityactivatesublocalizationsexceptGolgicomplexalsodemonstratesusceptibilitydependsposttranslationalmodifications:activatedRasGRF1whereasgeranylgeranylatedunresponsiveImportantlycatalyzeresidespleckstrinhomology1domainmechanismindependentlocalizationassociatemembranesFinallydataindicateCdc42-GDPinhibitdemonstratingCdc42negativelyaffectsfunctionsirrespectiveGTPasetargetedStructuraldeterminantsregulating

Similar Articles

Cited By